Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Donate today to give back in celebration of all that #PublicMediaGives. Your contribution will be matched $1 for $1.

Cheshire Medical Center to pay $2 million fine in fentanyl case

The exterior of Cheshire Medical Center
Paul Cuno-Booth
/
NHPR

This story was originally produced by the Keene Sentinel. NHPR is republishing it in partnership with the Granite State News Collaborative.

Cheshire Medical Center will pay $2 million in connection with the months-long incident where gallons of fentanyl solution were lost or unaccounted for at the Keene hospital.

"Cheshire Medical Center’s failure to fulfill its obligations under the Controlled Substance Act enabled the theft of prescription narcotics — including powerful opioids such as fentanyl, which led to a shockingly high percentage of drugs missing from CMS’s inventory. The failures uncovered warranted a multi-million-dollar penalty and a stringent corrective action plan," U.S. Attorney Jane Young said in a news release Wednesday from the Department of Justice announcing the settlement.

"This is one of the largest settlements of drug diversion claims against a hospital in the country."

The release says the Dartmouth Health affiliate failed to keep accurate records of controlled substances, including opioids.

The Drug Enforcement Administration began an investigation into Cheshire Medical after an ICU nurse reported in February 2022 that she'd stolen hundreds of bags of fentanyl solution from the hospital, according to documents from the N.H. Office of Professional Licensure and Certification (OPLC).

But following the nurse’s death that March, and after remedial measures were put in place, the documents state that drugs still went missing.

In connection with the months-long substance diversion, the OPLC disciplined Cheshire Medical’s chief nursing officer, pharmacist-in-charge/director of pharmacy and a pharmacist — none of whom are still employed by the hospital.

Audits from the DEA found the hospital had several "recordkeeping deficiencies, such as failing to maintain accurate purchase and dispensation records." Cheshire Medical also failed to regularly review reports to look for possible diversion, and did not enforce various controlled substance security policies, the audit shows.

This settlement resolves the allegations that the hospital violated the record-keeping requirements of the Controlled Substance Act and its regulations, according to the release. In addition to the $2 million fine, the release says Cheshire Medical has agreed to additional security and record-keeping measures.

These articles are being shared by partners in The Granite State News Collaborative. For more information visitcollaborativenh.org.

Related Content

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.